Navigation Links
Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
Date:12/15/2009

LAWRENCE, Mass., Dec. 15 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that a group of its home hemodialysis patients and their partners will be embarking on a week-long, conventional (non-dialysis) Caribbean cruise with their NxStage® System One(TM) cyclers. The cruise, dubbed the "2010 Freedom Cruise: We're Taking Home Dialysis to Sea," departs from Miami, Fla. on January 3, 2010 and returns on January 10, 2010. The NxStage System One is the first truly portable, easy-to-use hemodialysis system cleared for home use by the U.S. FDA.

"In the past, being a dialysis patient meant scheduling your life around your in-center treatment schedule," said NxStage home hemodialysis patient and cruise organizer Rich Berkowitz. "If we wanted to travel, we were limited to destinations where space at local dialysis centers was available, and arrangements had to be made weeks or months in advance. Cruises like this were only possible with a dialysis medical team onboard. We are excited to show other dialysis patients that we, too, can enjoy the freedom and flexibility that others have by traveling with our System Ones. Dialysis doesn't have to be the end of 'normal' living, but rather a new beginning."

The innovative design of the NxStage System One - its small size relative to other hemodialysis equipment, standard electrical connections, and bagged solutions - make it uniquely portable to support NxStage patients' ability to take their therapy with them when they travel. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, at home or on vacation. In the years that the NxStage System One has been available, numerous patients have, with the approval of their doctor and center, taken cruises with their NxStage systems, but this is the first known large group, patient-organized cruise by home hemodialysis patients using the NxStage System One.

"We are thrilled to see our patients and their partners truly celebrating the health and flexibility benefits of home hemodialysis with our System One," said Jeffrey H. Burbank, chief executive officer of NxStage Medical. "This cruise underscores our mission to help dialysis patients lead full and vibrant lives, and we hope that this is just one of many trips in the future."

To enable flexibility and travel, NxStage supports patient travel to destinations and ports within the United States at no additional charge, upon receipt of a physician's prescription and per the company's travel policy guidelines. Patients interested in traveling with their NxStage System One can request a copy of the travel guidelines packet through NxStage Customer Service at 1-866-NXSTAGE.

NxStage Medical is not sponsoring or organizing the cruise but is supporting the shipment of supplies to the Miami port for cruise participants, as outlined in the travel policy. More information about the 2010 Freedom Cruise can be found at www.billpeckham.com/cruise/2010-freedom-cruise-information-central.html or on NxStage's website at www.nxstage.com/FreedomCruise, where regular updates will be posted.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of End Stage Renal Disease (ESRD) and acute kidney failure. For more information on NxStage and its products, please visit NxStage's website at www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond NxStage's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance or achievements, including market acceptance and demand for NxStage's products, growth in home and/or daily hemodialysis, and other factors that are discussed in NxStage's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the period ended September 30, 2009.


    Investor Relations Contact
    --------------------------
    Kristen Sheppard
    NxStage Medical, Inc.
    ir@nxstage.com
    978-332-5923

    Media Contact
    -------------
    Jim Weinrebe
    Schwartz Communications, Inc.
    nxstage@schwartz-pr.com
    781-684-0770

SOURCE NxStage Medical, Inc.


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
2. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
3. Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies
4. Reprocessed Catheters: A Growing Force In the US Electrophysiology Diagnostic Catheter Market, According to Millennium Research Group
5. DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
6. Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
7. WellTek/MedX Group Completes Major Reorganization
8. Hill-Rom and Encompass Group Form Joint Venture
9. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
10. EDI Health Group Partners With Orthoease to Incorporate Claims Processing Into Companys Robust Practice Management Software
11. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 2016  The ALS Association, in partnership with ALS Finding ... generate a biomarker to track TDP43 aggregation. The successful team(s) ... $1 million investment. --> ... nerve cells in the brain and the spinal cord. Eventually, ... muscle movement, which often leads to total paralysis and death ...
(Date:2/10/2016)... VIEW, Calif. , Feb. 10, 2016 ... of a synergistic confluence of various technologies ... value propositions, previously unavailable. These opportunities create ... and convergence, in turn, drives the development ... entrepreneurial scenario is characterized by technology convergences, ...
(Date:2/10/2016)... 2016 Antibacterial Drugs Market - Global ... 2023 ", reveals that the global antibacterial drugs market is ... 2023 owing to patent expiries of blockbuster drugs. Even though ... the forecast period, the value is anticipated to decline from ... --> Antibacterial Drugs Market - Global Industry Analysis, Size, ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... ... Gout is like no other joint pain. It strikes suddenly, like flicking on ... redness. It is triggered by the crystallization of uric acid within the joints. It ... to the February 2016 issue of Harvard Men's Health Watch. , The large joint ...
(Date:2/10/2016)... Carefree, AZ (PRWEB) , ... February 10, 2016 , ... ... coach in new book , Pioneering book "Better with Age: The Ultimate Guide to ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... FL 32224, February 26th: Amateur & Professional Divisions - Time: 7:00pm – ... – 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: ...
(Date:2/10/2016)... ... ... A new leadership team for Mid-South Youth Camp, operated by Freed-Hardeman University, will ... night, Feb. 8, prior to the evening session of the university’s 80th Annual Bible ... Camp, has been named director. Gayle McDonald, currently the assistant director of MSYC, will ...
(Date:2/10/2016)... ... ... It’s that time of year when most people have forgotten all about their New ... (IAAM), Hall of Fame athlete and Garrison Forest School athletic director since 2005, knows ... of her first decisions when her IAAM two-year presidency began last July was to ...
Breaking Medicine News(10 mins):